Retention periods: regulatory requirements, sponsor agreements, and institutional policies: and what governs when they conflict
Teaches the analytical framework for resolving retention period conflicts and the tracking system that manages retention across a portfolio of closed studies spanning different years, sponsors, and regulatory regimes.
The question that follows archiving
Lesson 2 taught you how to archive records properly -- completeness verified, format preserved, transfer documented, storage confirmed. The archived study now sits in its designated location, protected by the five measures of Section 2.12.12. But the regulatory coordinator faces an immediate next question, and it is deceptively simple: how long must those records stay there?
I say deceptively simple because the answer is almost never a single number. A regulatory coordinator managing a portfolio of 15 or 20 closed studies will discover that different studies carry different retention obligations, imposed by different authorities, measured from different starting points, and -- not infrequently -- contradicting one another. One sponsor's clinical trial agreement specifies 15 years from study completion. Another specifies "until two years after the last marketing approval in the ICH region." The FDA regulation ties retention to drug approval status. The institution's own records retention policy imposes a blanket 25-year minimum for all research records.
Which one governs?
ICH E6(R3) provides the answer in a single sentence -- Section 2.12.12 -- but applying that sentence to a real portfolio requires an analytical framework that this lesson will build. The framework has three components: understanding the hierarchy of retention requirements, designing the tracking system that manages retention across the portfolio, and resolving the conflict scenarios that arise when different authorities impose different periods.
This is not a topic where approximation is acceptable. If the regulatory coordinator gets the retention period wrong -- destroys records too early, or fails to track when destruction becomes eligible -- the consequences range from regulatory noncompliance to the irreversible loss of records that may still be needed for ongoing regulatory proceedings, litigation, or public health inquiries. The records themselves are already archived. What this lesson teaches is the infrastructure that determines when they may leave.
What you will learn
By the end of this lesson, you will be able to: